Relevance of AIDS treatment with two nucleoside analogues alone

A report on meta-analysis that summarizes much of what has been learned about the use of zidovudine alone or in combination with didanosine or zalcitabine is discussed.

Saved in:
Bibliographic Details
Published inThe Lancet (British edition) Vol. 353; no. 9169; pp. 1989 - 1990
Main Authors Weidle, PJ, Mbidde, E, Djomand, G, Lackritz, EM
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 12.06.1999
Elsevier Limited
Subjects
Acquired immune deficiency syndrome
Acquired Immunodeficiency Syndrome - drug therapy
Acquired Immunodeficiency Syndrome - mortality
AIDS
AIDS/HIV
Anti-HIV Agents - administration & dosage
Didanosine - administration & dosage
Drug therapy
Drug Therapy, Combination
Humans
Medical research
Survival Rate
Systematic review
Zalcitabine - administration & dosage
Zidovudine - administration & dosage
Online AccessGet full text

Cover

More Information
Summary:A report on meta-analysis that summarizes much of what has been learned about the use of zidovudine alone or in combination with didanosine or zalcitabine is discussed.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Commentary-1
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(99)00161-0